A UK retrospective look at outcomes for 84 patients receiving definitive proton therapy for localized rhabdomyosarcoma reports outcomes comparable to cooperative group trials, with all local failures occurring in-field within the high-dose volume and with parameningeal site, intracranial extension and advanced T stage continuing to predict intractable disease. | Mortada Elsharief, Int J Radiat Oncol Biol Phys 2026
